Glembatumumab vedotin represents an new approach in malignancy therapy. This targeted agent specifically recognizes a receptor expressed on multiple tumor cells, releasing a effective chemotherapeutic drug. Initial https://bookmarklinking.com/story11153790/glemba-vedotin-a-encouraging-targeted-therapy-for-malignancy-management